Pneumothorax is very rare after early phase of hematopoietic stem cell transplantation (HSCT) and usually accompanied with pulmonary chronic graft-versus-host disease (GVHD), such as bronchiolitis obliterans and bronchiolitis obliterans organizing pneumonia. The present study describes the case of a seventeen-year-old male diagnosed with acute myeloid leukemia who underwent allogeneic bone marrow transplantation (BMT). Pneumothorax occurred at day 43 after BMT. Pneumothorax occurred in early phase of HSCT is extremely rare. The early onset of acute GVHD and the entity of cytomegalovirus might worsen the pulmonary tissue damages for the onset of pneumothorax, indicating that we should be aware of the possibility to occur pneumothorax even in the early period after allogeneic HSCT.
Introduction
Allogeneic hematopoietic stem cell transplantation (HSCT) is currently a curative treatment option for many hematologic diseases. These recipients are at a high risk for pulmonary complications, which occur in 40-60% of transplanted recipients, and account for approximately 10-40% of transplant-related death. [1] [2] [3] In the pulmonary complications, pneumothorax is rare, and most cases of pneumothorax reported previously were accompanied with pulmonary chronic graft-versus-host disease (cGVHD) in a late phase after HSCT. [4] [5] [6] [7] [8] [9] [10] Here, we described a case of pneumothorax which occurred in an early phase after allogeneic HSCT.
Case Report
A 17 year-old male was diagnosed as acute myeloid leukemia with T lymphoblastic lymphoma, which was transformed from 8p11 myeloproliferative syndrome with chimeric CEP110-FGFR1 fusion transcript. Because of the absence of HLA-matched related or unrelated donor, he underwent myeloablative allogeneic bone marrow transplantation (BMT) from HLA-DR 1 locus mismatched unrelated female donor. On day 16 after BMT, grade III acute GVHD (aGVHD: skin, stage 3; liver, stage 0; gut, stage 2) developed. Then he received prednisolone (PSL) in addition to tacrolimus for GVHD prophylaxis. Twelve days after using PSL and tacrolims, aGVHD was almost improved. The engraftment of neutrophils was observed on day 22. Hematological complete remission and complete chimera in BM were obtained on day 31, but since chimeric CEP110-FGFR1 fusion transcript still remained in real-time quantitative polymerase chain reaction analysis, immunosuppressant were tapered. On day 33, cytomegalovirus (CMV) pp65 antigenemia assay showed positive in his blood. Then he received ganciclovir (GCV), but the CMV positive cells still existed in his blood on day 40 even though he did not manifest any pulmonary symptoms. Therefore, GCV was changed to foscarnet (FCV), and the CMV positive cells were eliminated by several days of FCV administration. On day 43, he suddenly complained dyspnea, and chest x-ray and CT revealed the left collapsed lung and multiple pleural bullae in apex of left lung ( Figure 1A-C) , and no sign of pneumomediastinum nor subcutaneous emphysema. Then, we diagnosed as left pneumothorax, and chest drainage tube was inserted. One month later his left lung did not collapse without drainage ( Figure 1D, E) . Chest CT could not detect any pleural bullae before BMT. During this episode, we could not detect the sign of Pneumocystis pneumonia and aspergillosis infection.
Discussion
Pneumothorax after HSCT was rare, and reported cases with pneumothorax after HSCT were usually accompanied with pulmonary cGVHD, such as brochiolitis obliterans and bronchiolitis obliterans organizing pneumonia. 5, 6, 8 The incidence of air leak syndrome (ALS) including pneumothorax, pneumomediastinum and subcutaneous emphysema following HSCT was between 0.83-2.3%. [4] [5] [6] [7] ALS occurred within 100 days after HSCT was extremely rare complication. Moon et al. reported 18 cases of ALS including pneumothorax occurred after allogeneic HSCT. 6 Among them, the onsets of 15 cases were later than 100 days after HSCT (on days 183 to 1825), and only 3 cases occurred earlier than on day 100 (on days 55 to 60). In such cases of pneumothorax occurring in an early phase after HSCT, the damages caused by drugs and irradiation therapies in the pulmonary tissues might induce the tissue vulnerability, which could contribute to an easy rupture of alveolar and pleural tissues. Additionally, in the present case, the early onset of aGVHD and the entity of CMV might worsen the tissue damages for the onset of pneumothorax. Interestingly, the recipients with ALS were reported to have poor prognosis. 4, 5 Indeed, our patient died of progression of the primary disease three months after HSCT. Therefore, some of ALS after HSCT might be related to pulmonary infiltration of malignant cells.
Conclusions
Our experience indicated that we should be aware of the possibility that pneumothorax could occur in the early period after allogeneic HSCT although pneumothorax usually develops with the exacerbation of cGVHD in the late period after allogeneic HSCT, and carefully observe the clinical course of the patients even after pneumothorax has been improved.
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